Suppressors of cytokine signaling in health and disease

被引:84
作者
Tan, JC
Rabkin, R
机构
[1] Vet Affairs Palo Alto Hlth Care Syst, Res Serv, Palo Alto, CA 94304 USA
[2] Stanford Univ, Dept Med, Div Nephrol, Stanford, CA 94305 USA
关键词
signal transducer and activator of transcription; Janus-kinase; cytokines; signal transduction; kidney disease;
D O I
10.1007/s00467-004-1766-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cytokines consist of a large family of secreted proteins, including pro-inflammatory agents, growth hormone and erythropoietin, that utilize the Janus kinase (JAK) signal transducer and activator of transcription (STAT) signal transduction pathway to mediate many of their key physiologic and pathologic actions. These actions include cytokine-mediated inflammation, immunoregulation, hematopoiesis and growth. The JAK-STAT pathway is regulated by several processes, among which negative feedback regulation by the suppressors of cytokine signaling (SOCS), members of a family of eight proteins, is particularly important. Each cytokine induces one or more specific SOCS proteins that in turn down-regulate the signal initiated by the cytokine. Through their impact on the cytokine-activated JAK-STAT pathway, the SOCS proteins are involved in many diseases that come to the attention of the pediatric nephrologist. For example, an increase in the expression of SOCS-2 and -3 may be a cause of growth hormone resistance and thus may contribute to the growth retardation that affects children with chronic renal failure. Because of their obvious biologic importance, the SOCS proteins have been the subject of intense research that includes the development of strategies to utilize these proteins to control cytokine-induced JAK/STAT signal transduction for therapeutic purposes.
引用
收藏
页码:567 / 575
页数:9
相关论文
共 81 条
[1]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[2]   A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis [J].
Atsumi, T ;
Ishihara, K ;
Kamimura, D ;
Ikushima, H ;
Ohtani, T ;
Hirota, S ;
Kobayashi, H ;
Park, SJ ;
Saeki, Y ;
Kitamura, Y ;
Hirano, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) :979-990
[3]   Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli [J].
Banes, AK ;
Shaw, S ;
Jenkins, J ;
Redd, H ;
Amiri, F ;
Pollock, DM ;
Marrero, MB .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (04) :F653-F659
[4]   Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure [J].
Booz, GW ;
Day, JNE ;
Baker, KM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (11) :1443-1453
[5]   STATs in oncogenesis [J].
Bowman, T ;
Garcia, R ;
Turkson, J ;
Jove, R .
ONCOGENE, 2000, 19 (21) :2474-2488
[6]   Stat proteins and oncogenesis [J].
Bromberg, J .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (09) :1139-1142
[7]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[8]   Suppressor of cytokine signaling 3 is induced by angiotensin II in heart and isolated cardiomyocytes, and participates in desensitization [J].
Calegari, VC ;
Bezerra, RMN ;
Torsoni, MA ;
Torsoni, AS ;
Franchini, KG ;
Saad, MJA ;
Velloso, LA .
ENDOCRINOLOGY, 2003, 144 (10) :4586-4596
[9]   STAT proteins:: From normal control of cellular events to tumorigenesis [J].
Calò, V ;
Migliavacca, M ;
Bazan, V ;
Macaluso, M ;
Buscemi, M ;
Gebbia, N ;
Russo, A .
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 197 (02) :157-168
[10]  
Carter-Su C, 2000, RECENT PROG HORM RES, V55, P293